Phase II study of erlotinib (Tarceva, OSI774) in women with recurrent or metastatic endometrial cancer - NCICIND 148. Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Oza, AM
  • Elit, Laurie
  • Eisenhauer, E
  • Hoskins, PJ
  • Biagi, J
  • Carey, M
  • Dubuc-Lissoir, J
  • Dundas, G
  • Stuart, G
  • Matthews, S
  • Tsao, M
  • Dancey, J
  • Fyles, A

publication date

  • December 1, 2003